141 related articles for article (PubMed ID: 19275639)
1. Prodigiosins as anti cancer agents: living upto their name.
Pandey R; Chander R; Sainis KB
Curr Pharm Des; 2009; 15(7):732-41. PubMed ID: 19275639
[TBL] [Abstract][Full Text] [Related]
2. The prodigiosins: a new family of anticancer drugs.
Montaner B; Pérez-Tomás R
Curr Cancer Drug Targets; 2003 Feb; 3(1):57-65. PubMed ID: 12570661
[TBL] [Abstract][Full Text] [Related]
3. Prodigiosins: a novel family of immunosuppressants with anti-cancer activity.
Pandey R; Chander R; Sainis KB
Indian J Biochem Biophys; 2007 Oct; 44(5):295-302. PubMed ID: 18341204
[TBL] [Abstract][Full Text] [Related]
4. The prodigiosins, proapoptotic drugs with anticancer properties.
Pérez-Tomás R; Montaner B; Llagostera E; Soto-Cerrato V
Biochem Pharmacol; 2003 Oct; 66(8):1447-52. PubMed ID: 14555220
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
Manderville RA
Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
[TBL] [Abstract][Full Text] [Related]
6. Biological Potential and Mechanism of Prodigiosin from
Li D; Liu J; Wang X; Kong D; Du W; Li H; Hse CY; Shupe T; Zhou D; Zhao K
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400387
[TBL] [Abstract][Full Text] [Related]
7. New insights on the antitumoral properties of prodiginines.
Pérez-Tomás R; Viñas M
Curr Med Chem; 2010; 17(21):2222-31. PubMed ID: 20459382
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antineoplastic property of prodigiosins and 5-fluorouracil in restraining the growth of Ehrlich solid tumors in mice.
Hassan ESE; Shafaa MW; Faraag AHI; Essawy E; Bakkar AA; Al-Megrin WA; El-Khadragy MF; Abdelfattah MS; Abdel Moneim AE
Environ Sci Pollut Res Int; 2022 Nov; 29(55):83723-83732. PubMed ID: 35773616
[TBL] [Abstract][Full Text] [Related]
9. Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years.
Fürstner A
Angew Chem Int Ed Engl; 2003 Aug; 42(31):3582-603. PubMed ID: 12916029
[TBL] [Abstract][Full Text] [Related]
10. Properties and applications of undecylprodigiosin and other bacterial prodigiosins.
Stankovic N; Senerovic L; Ilic-Tomic T; Vasiljevic B; Nikodinovic-Runic J
Appl Microbiol Biotechnol; 2014 May; 98(9):3841-58. PubMed ID: 24562326
[TBL] [Abstract][Full Text] [Related]
11. Development of natural anti-tumor drugs by microorganisms.
Chang CC; Chen WC; Ho TF; Wu HS; Wei YH
J Biosci Bioeng; 2011 May; 111(5):501-11. PubMed ID: 21277252
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of human lung adenocarcinoma A549 cells induced by prodigiosin analogue obtained from an entomopathogenic bacterium Serratia marcescens.
Zhou W; Jin ZX; Wan YJ
Appl Microbiol Biotechnol; 2010 Dec; 88(6):1269-75. PubMed ID: 20717667
[TBL] [Abstract][Full Text] [Related]
13. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
14. Reversible and potent uncoupling of hog gastric (H(+)+K(+))-ATPase by prodigiosins.
Matsuya H; Okamoto M; Ochi T; Nishikawa A; Shimizu S; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
Biochem Pharmacol; 2000 Dec; 60(12):1855-63. PubMed ID: 11108801
[TBL] [Abstract][Full Text] [Related]
15. Prodigiosins uncouple lysosomal vacuolar-type ATPase through promotion of H+/Cl- symport.
Ohkuma S; Sato T; Okamoto M; Matsuya H; Arai K; Kataoka T; Nagai K; Wasserman HH
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):731-41. PubMed ID: 9729483
[TBL] [Abstract][Full Text] [Related]
16. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue.
Tomlinson JT; Park G; Misenheimer JA; Kucera GL; Hesp K; Manderville RA
Org Lett; 2006 Oct; 8(21):4951-4. PubMed ID: 17020344
[TBL] [Abstract][Full Text] [Related]
17. The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.
Soto-Cerrato V; Viñals F; Lambert JR; Pérez-Tomás R
Biochem Pharmacol; 2007 Nov; 74(9):1340-9. PubMed ID: 17765876
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-mediated apoptosis operating irrespective of multidrug resistance in breast cancer cells by the anticancer agent prodigiosin.
Soto-Cerrato V; Llagostera E; Montaner B; Scheffer GL; Perez-Tomas R
Biochem Pharmacol; 2004 Oct; 68(7):1345-52. PubMed ID: 15345324
[TBL] [Abstract][Full Text] [Related]
19. Anion transporters and biological systems.
Gale PA; Pérez-Tomás R; Quesada R
Acc Chem Res; 2013 Dec; 46(12):2801-13. PubMed ID: 23551251
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic prodigiosin family pigments from Pseudoalteromonas sp. 1020R isolated from the Pacific coast of Japan.
Wang Y; Nakajima A; Hosokawa K; Soliev AB; Osaka I; Arakawa R; Enomoto K
Biosci Biotechnol Biochem; 2012; 76(6):1229-32. PubMed ID: 22790952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
